|Videos|November 7, 2021
Expert Discusses Limitations of Vascular Calcification Treatments
Paolo Raggi, MD, PhD, professor at the department of medicine in the division of cardiology at the University of Alberta, discusses how pharmacists are limited to traditional treatment of chronic kidney disease, while waiting for new treatment options.
Advertisement
In a Pharmacy Times® interview, Paolo Raggi, MD, PhD, professor at the department of medicine in the division of cardiology at the University of Alberta, about his ASN 2021 Kidney Week presentation on the prevention of vascular calcification in chronic kidney disease (CKD).
He discussed how pharmacists are limited to traditional treatment of CKD, while waiting for new treatment options.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
White House Expands TrumpRx, Adding Over 600 Generic Medications
2
GLP-1 Boosters: Responding to Supplement Marketing Claims and Safety Questions
3
Oral GLP-1 Orforglipron Approved for Obesity
4
GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease
5